Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Pharmasum Therapeutics A/S
DescriptionDual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A) inhibitor
Molecular Target Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A)
Mechanism of ActionKinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentDiscovery
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD) in Down syndrome patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today